Stock 600332 GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Shanghai S.E.

Equities

600332

CNE000001733

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
29.33 CNY +0.34% Intraday chart for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited -0.44% +2.55%
27/06 Guangzhou Baiyunshan Pharmaceutical Secures Drug Registration for Erectile Dysfunction Tablets MT
19/06 Baiyunshan Pharmaceutical's Unit Gets Regulatory Nod to Add Specification for Dopamine Hydrochloride Injection MT

ETFs positioned on Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Name Weight AuM 1st Jan change Investor Rating
KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX UCITS ETF - USD ETF KraneShares MSCI All China Health Care Index UCITS ETF - USD
0.72% 1 M€ -23.55% -
GOLDMAN SACHS ACTIVEBETA EMERGING MARKETS EQUITY UCITS ETF - ACC - USD ETF Goldman Sachs ActiveBeta Emerging Markets Equity UCITS ETF - Acc - USD
0.10% 11 M€ +6.33%
ICBCCS S&P CHINA 500 UCITS ETF CLASS B - USD ETF ICBCCS S&P China 500 UCITS ETF Class B - USD
0.06% 35 M€ -5.85% -
KRANESHARES MSCI CHINA ESG LEADERS ETF - USD ETF KraneShares MSCI China ESG Leaders ETF - USD
0.05% 4 M€ -11.56%
KRANESHARES MSCI CHINA ESG LEADERS UCITS ETF ACC - USD ETF KraneShares MSCI China ESG Leaders UCITS ETF Acc - USD
0.05% 2 M€ -2.29% -
LEADERSHARES EQUITY SKEW ETF - USD ETF LeaderShares Equity Skew ETF - USD
0.01% 114 M€ +6.26% -
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Emerging Markets Plus Downside Convexity ETF - USD
0.01% 4 M€ -4.41% -
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (D) - EUR ETF AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (D) - EUR
0.00% 451 M€ +8.79% -
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (C) - EUR ETF AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (C) - EUR
0.00% 2,838 M€ +11.35% -
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF - USD ETF AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF - USD
0.00% 152 M€ +7.71% -
DEMOCRACY INTERNATIONAL FUND ETF - USD ETF Democracy International Fund ETF - USD
0.00% 7 M€ +3.37% -
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD ETF Day Hagan/Ned Davis Research Smart Sector International ETF - USD
0.00% 35 M€ +4.85% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF Acc - EUR
0.00% 414 M€ +12.00% -
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 80% Equity UCITS ETF - Distributing - EUR
0.00% 36 M€ +10.49% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Distributing - EUR
0.00% 40 M€ +7.33% -
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR ETF Vanguard LifeStrategy 60% Equity UCITS ETF - Acc - EUR
0.00% 324 M€ +8.15% -
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 32 M€ +4.15% -
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 40% Equity UCITS ETF Acc - EUR
0.00% 104 M€ +5.59% -
VANGUARD LIFESTRATEGY 20% EQUITY UCITS ETF ACC - EUR ETF Vanguard LifeStrategy 20% Equity UCITS ETF Acc - EUR
0.00% 55 M€ +1.95% -
NOMURA NEXT FUNDS EMERGING MARKET EQUITY MSCI-EM (UNHEDGED) ETF - JPY ETF Nomura NEXT FUNDS Emerging Market Equity MSCI-EM (Unhedged) ETF - JPY
0.00% 15 M€ +22.33%

Company Profile

Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. specializes in researching, developing and manufacturing pharmaceutical products. The group's products include analgesics, antibiotics, medicines for the treatment of stomach disorders, treatment of cough, antitoxic products, etc.
Sector
Pharmaceuticals
Calendar
16/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
19.22 CNY
Average target price
23.96 CNY
Spread / Average Target
+24.68%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.61% 819B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.44% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.46% 329B
ABBVIE INC. Stock AbbVie Inc.
+9.54% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 225B
NOVARTIS AG Stock Novartis AG
+13.31% 217B
AMGEN INC. Stock Amgen Inc.
+8.26% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.99% 158B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 874 Stock
  4. 600332 Stock
  5. Funds and ETFs Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited